Collectively, GC intervention may reduce RA-induced joint inflammation and alleviate joint swelling and damage by inhibiting LPS-producing bacteria, lowering LPS synthesis, and thereby suppressing the activation of the TLR-4/NF-κB pathway in joint tissues. The gene discussed is TLR4; the disease is rheumatoid arthritis.